Potential Impact of DPYD Variation on Fluoropyrimidine Drug Response in sub-Saharan African Populations
Cancer is a critical health burden in Africa, and mortality rates are rising rapidly. Treatments are expensive and often cause adverse drug reactions (ADRs). Fluoropyrimidine treatments can lead to severe toxicity events which have been linked to variants within the dihydropyrimidine dehydrogenase (...
Main Authors: | Jorge E. B. da Rocha, Zané Lombard, Michèle Ramsay |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.626954/full |
Similar Items
-
A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
by: Chi C. Tong, et al.
Published: (2018-07-01) -
DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01) -
A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature
by: Valeria Conti, et al.
Published: (2020-09-01) -
<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
by: Theodore J. Wigle, et al.
Published: (2019-05-01) -
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple <i>DPYD</i> Variants
by: Carin A. T. C. Lunenburg, et al.
Published: (2018-11-01)